Background: Hypoperfusion intensity ratio (HIR) and cerebral blood volume index (CBVI) have been shown to predict clinical outcome, but further validation is needed in patients initially presenting to non-thrombectomy centers. Methods: We conducted a retrospective study of patients with an anterior circulation large vessel occlusion (ACLVO) who underwent computed tomography perfusion (CTP) scanning at a non-thrombectomy center and were transferred for consideration of thrombectomy. We evaluated the association of three measures of collateral status (HIR, CBVI, and a collateral score combining both measures) to 90-day modified Rankin scale (mRS). Results: We identified 497 eligible patients, of whom 93% underwent thrombectomy. After adjusting for covariates, ascending numerical CBVI was associated with 90-day mRS ≤ 2 in both overall patients and the recanalized subgroup ( n = 436). In the recanalized subgroup, 90-day mRS ≤ 2 among patients with CBVI > 0.7 was 56% versus 36% with CBVI ≤ 0.7 [adjusted OR: 1.73 (1.13–2.65), p = 0.012]. Neither HIR thresholds below 0.4, 0.5, and 0.6, nor a good versus poor collateral score, were associated with independent or improved functional outcome,. Conclusion: In this study of ACLVO patients transferred for thrombectomy consideration, ascending numeric CBVI was associated with independent function in both the overall population and the recanalized subgroup, and CBVI > 0.7 was associated with both independent and improved functional outcome in recanalized patients. Among CTP measures of collateral status, CBVI alone may play an important role in stroke prognostication and management for ACLVO patients who initially present to a non-thrombectomy center.
Patient-reported, health-related quality of life (QOL) metrics that capture elements not always accounted for by traditional scales are increasingly recognized as important measures but are still under-utilized. We studied QOL in a recent cohort of endovascular thrombectomy (EVT) patients. We conducted a multicenter, prospective, observational study of patients treated with EVT. The primary and secondary outcome measures were 90-day EuroQol 5-Dimension 5-Level index (EQ index, scores -0.573 to 1) and the Visual Analog Scale (VAS, 0-100), respectively. Spearman correlation was used to assess correlations between the EQ index and VAS with the 90-day modified Rankin Scale (mRS) and between each EuroQol domain and 90-day mRS. Linear regression was performed to identify factors associated with the outcomes. 212 subjects (mean age 68.4 ± 14.7 years, median NIHSS 15 [interquartile range 10-20]) were included. Mean EQ index was 0.45 ± 0.42 and median VAS was 75 (interquartile range 60-90). Over 40% of subjects reported at slight problems or worse in each QOL domain and nearly 80% reported such problems in at least one domain. EQ index and 90-day mRS were strongly correlated in the full cohort (rs= -0.912, p<0.001) and in survivors (rs= -0.709, p<0.001). In the multiple linear regression analyses, premorbid mRS, cerebral blood volume index, and length of stay appeared to be associated with EQ index and VAS. Ninety-day QOL measures may provide useful information as an adjunct to mRS scoring in selected stroke thrombectomy patients.